中文 | English
Return
Total: 89 , 1/9
Show Home Prev Next End page: GO
Author:(Ze-Zhou XIAO)

1.Application of Bayesian Methods for laboratory to clinical translation and for identifying hidden subpopulations

David Z. D'Argenio ; Xiao-ning WANG ; Ze-xun ZHOU

Chinese Journal of Clinical Pharmacology and Therapeutics 2007;12(10):1114-1121

2.Development of a novel screening assay for inhibitors targeting HIF-1alpha and P300 interaction.

Fang-Fang LAI ; Fei NIU ; Han-Ze YANG ; Wan-Qi ZHOU ; Xiao-Guang CHEN

Acta Pharmaceutica Sinica 2014;49(6):849-853

3.Distribution of Genetic Polymorphisms about CYP2C19 Gene in the Elderly Chinese Han Populations of Guangzhou and the Comparison in Different Populations

Xuanhao XIAO ; Tao ZENG ; Xiuxia LEI ; Ze LI ; Jin ZHOU ; Zhiyuan WANG ; Xiaoping PAN

Journal of Sun Yat-sen University(Medical Sciences) 2017;38(2):307-314

4.Discussion on Clinical and Diagnosis Program of Integrative Medicine.

Yi-di ZENG ; Ze-biao CAO ; Jia DU ; Jing-jie TAO ; Xiao-qing ZHOU

Chinese Journal of Integrated Traditional and Western Medicine 2016;36(5):517-521

5.Preparation of corn polysaccharide-Fe(Ⅲ) complex and assay of Fe(Ⅲ)

xiao-lei, DENG ; jian-hua, ZHANG ; jin-e, ZHOU ; ze-nai, CHEN ; yang, LU

Journal of Shanghai Jiaotong University(Medical Science) 2006;0(11):-

6.Traightened on Chinese endemic seed plant species of medicine plants used in Tibetan medicine.

Hua-rong ZHOU ; Ze-jing MU ; Xiao-lang DU ; Jun-wei HE ; Lan CAO ; Guo-yue ZHONG

China Journal of Chinese Materia Medica 2015;40(17):3463-3469

7.Clinical analysis on 75 cases of aluminosis caused by black fused alumina.

Juan-juan PENG ; Ze-shen ZHOU ; Fei-yun WANG ; Xiao SHEN

Chinese Journal of Industrial Hygiene and Occupational Diseases 2005;23(4):286-289

8.Mutation screening of SCN1A 3′ untranslated region on Dravet syndrome patients and functional analysis of the variant

Tao ZENG ; Xuanhao XIAO ; Fuli MIN ; Shuda CHEN ; Ze LI ; Xiaoping PAN ; Jin ZHOU ; Yuesheng LONG ; Weiping LIAO

Chinese Journal of Neurology 2017;50(4):261-265

9.Hepatitis B virus X protein regulates the mEZH2 promoter via the E2F1-binding site in AML12 cells.

Xiao-Yan SHI ; Ying-Ying ZHANG ; Xiao-Wei ZHOU ; Jian-Sheng LU ; Ze-Kun GUO ; Pei-Tang HUANG

Chinese Journal of Cancer 2011;30(4):273-279

10.Ornithine aspartate and naloxone combined therapy for hepatic encephalopathy affects cognitive function, prognosis, and neuropeptide levels.

Ze-wen ZHOU ; Xiao-ni ZHONG ; Bao-yong ZHOU ; Ji-feng XIANG ; Run-hua WANG ; Jing YI

Chinese Journal of Hepatology 2013;21(5):385-388

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 89 , 1/9 Show Home Prev Next End page: GO